The 26 analysts offering 12-month price forecasts for Biogen Inc have a median target of 320.00, with a high estimate of 394.00 and a low estimate of 239.00. The median estimate represents a +37.19% increase from the last price of 233.26.
The current consensus among 33 polled investment analysts is to Buy stock in Biogen Inc. This rating has held steady since November, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $4.17
Reporting Date Feb 01
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.